Net Pals Net Pals
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Reels
  • Blogs
  • Marketplace
  • Offres
  • Emplois
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • nk99fmi Ajouter une nouvelle offre d'emploi Health
    2026-09-02 20:05:26 - Traduire -
    HER2 Therapy Market Demand: Expanding Use of Targeted Therapies in HER2-Positive Cancer
    The HER2 therapy market is projected to grow from USD 16.8 billion in 2026 to USD 38.7 billion by 2036, registering a CAGR of 8.7%, according to Future Market Insights. The market is gaining momentum as advances in biomarker testing expand treatment eligibility and pharmaceutical companies develop targeted therapies for HER2-positive, HER2-low, and HER2-ultralow cancers. The market is expected...
    0 Commentaires 0 Parts 3 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Subhayan2 Ajouter une nouvelle offre d'emploi Autre
    2026-06-12 10:21:56 - Traduire -
    United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
    The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...
    0 Commentaires 0 Parts 1KB Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 Net Pals French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Cookies Acceptable Use Contactez nous Annuaire